Latent information in fluency lists predicts functional decline in persons at risk for Alzheimer disease

Cortex

Volumn 55, Issue 1, 2014, Pages 202-218

  Clark, D G ^a,b   Kapur, P ^c   Geldmacher, D S ^b   Brockington, J C ^b   Harrell, L ^b   DeRamus, T P ^d   Blanton, P D ^a   Lokken, K ^a   Nicholas, A P ^a,b   Marson, D C ^b  

^a BIRMINGHAM VA MEDICAL CENTER   (United States)

^b University of Alabama at Birmingham   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Alzheimer's disease; Cognitive neuropsychology; Dementia; Machine learning; MCI (mild cognitive impairment); Random forests

Indexed keywords

ACCURACY; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL DEMENTIA RATING SUM OF BOXES; COGNITION; CONTROLLED STUDY; CONVERGENT VALIDITY; FEMALE; FINANCIAL CAPACITY INSTRUMENT; FOLLOW UP; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; OUTCOME VARIABLE; PREDICTION; PREDICTIVE VALUE; PSYCHOLOGIC TEST; RANDOM FOREST; RISK FACTOR; SEMANTICS; SPEECH; AREA UNDER THE CURVE; ARTIFICIAL INTELLIGENCE; CASE CONTROL STUDY; COMPLICATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; RISK; SPEECH DISORDERS;

AGED; ALZHEIMER DISEASE; AREA UNDER CURVE; ARTIFICIAL INTELLIGENCE; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; REPRODUCIBILITY OF RESULTS; RISK; ROC CURVE; SEMANTICS; SPEECH; SPEECH DISORDERS;

EID: 84901433593     PISSN: 00109452     EISSN: 19738102     Source Type: Journal    
DOI: 10.1016/j.cortex.2013.12.013     Document Type: Article

References (57)

1. Abwender D., Swan J., Bowerman J., Connolly S. Qualitative analysis of verbal fluency output: review and comparison of several scoring methods. Assessment 2001, 8(3):323-336.
2. Bakkour A., Morris J., Dickerson B. The cortical signature of prodromal AD: regional thinning predicts mild AD dementia. Neurology 2009, 72:1048-1055.
3. Breiman L. Random forests. Machine Learning 2001, 45:5-32.
4. Chapman R., Mapstone M., McCrary J., Gardner M., Porsteinsson A., Sandoval T., et al. Predicting conversion from mild cognitive impairment to Alzheimer's disease using neuropsychological tests and multivariate methods. Journal of Clinical and Experimental Neuropsychology 2011, 33(2):187-199.
5. Clark D. Residual vectors for Alzheimer disease diagnosis and prognostication. Brain and Behavior 2011, 1(2):142-152.
6. Clark L., Gatz M., Zheng L., Chen Y., McCleary C., Mack W. Longitudinal verbal fluency in normal aging, preclinical and prevalent Alzheimer disease. Americal Journal of Alzheimer's Disease and Other Dementias 2009, 24(6):461-468.
7. Convit A., de Asis J., de Leon M., Tarshish C., De Santi S., Rusinek H. Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-dementia elderly predict decline to Alzheimer's disease. Neurobiology of Aging 2000, 21:19-26.
8. Cui Y., Liu B., Luo S., Zhen X., Fan M., Liu T., et al. Identification of conversion from mild cognitive impairment to Alzheimer's disease using multivariate predictors. PLOS One 2011, 6(7):1-10.
9. Davatzikos C., Bhatt P., Shaw L., Batmanghelich K., Trojanowski J. Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification. Neurobiology of Aging 2011, 32:19-27.
10. Delis D., Kramer J., Kaplan E., Ober B. California verbal learning test 2000, Psychological Corporation, San Antonio, TX. 2nd ed.
11. Devanand D., Liu X., Tabert M., Pradhaban G., Cuasay K., Bell K., et al. Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biological Psychiatry 2008, 64(10):871-879.
12. Doody R., Ferris S., Salloway S., Sun Y., Goldman R., Watkins W., et al. Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial. Neurology 2009, 72(18):1555-1561.
13. Duff-Canning S., Leach L., Stuss D., Ngo L., Black S. Diagnostic utility of abbreviated fluency measures in Alzheimer disease and vascular dementia. Neurology 2004, 62:556-562.
14. Fagundo A., Lopez S., Romero M., Guarch J., Marcos T., Salamero M. Clustering and switching in semantic fluency: predictors of the development of Alzheimer's disease. International Journal of Geriatric Psychiatry 2008, 23:1007-1013.
15. Folstein M., Folstein S., McHugh P. Mini-Mental State: a practical guide for grading the cognitive state of the patient for the physician. Journal of Psychiatry Research 1975, 12:189-198.
16. Freund Y., Schapire R. A decision-theoretic generalization of on-line learning and an application to boosting. Journal of Computer and System Sciences 1997, 55(1):119-139.
17. Furney S., Kronenberg D., Simmons A., Guentert A., Dobson R., Proitsi P., et al. Combinatorial markers of mild cognitive impairment conversion to Alzheimer's disease - cytokines and MRI measures together predict disease progression. Journal of Alzheimer's Disease 2011, 26:395-405.
18. Griffith H., Belue K., Sicola A., Krzywanski S., Zamrini E., Harrell L., et al. Impaired financial abilities in mild cognitive impairment: a direct assessment approach. Neurology 2003, 60(3):449-457.
19. Hinton G., Salakhutdinov R. Reducing the dimensionality of data with neural networks. Science 2006, 313(5786):504-507.
20. Hirshorn E., Thompson-Schill S. Role of the left inferior frontal gyrus in covert word retrieval: neural correlates of switching during verbal fluency. Neuropsychologia 2006, 44:2547-2557.
21. Hodges J.R., Patterson K. Is semantic memory consistently impaired early in the course of Alzheimer's disease? Neuroanatomical and diagnostic implications. Neuropsychologia 1995, 33(4):441-459.
22. Holland D., McEvoy L.K., Desikan R.S., Dale A.M., The Alzheimer's Disease Neuroimaging Inititive Enrichment and stratification for predementia Alzheimer's disease clinical trials. PLoS One 2012, 7(10):e47739.
23. Howard D., Patterson K. Pyramids and Palm Trees: A test of semantic access from pictures and words 1992, Harcourt Assessment, London.
24. Kaplan E., Goodglass H., Weintraub S. Boston naming test 1983, Lea & Febiger, Philadelphia.
25. Liaw A., Wiener M. Classification and regression by randomForest. R News 2002, 2(3):18-22.
26. Marchini J., Heaton C., Ripley B. fastICA: FastICA algorithms for perform ICA and projection pursuit, 1.1-16 2012, Retrieved from. http://cran.r-project.org/package=fastICA.
27. Marson D., Sawrie S., Snyder S., McInturff B., Stalvey T., Boothe A., et al. Assessing financial capacity in patients with Alzheimer disease: a conceptual model and prototype instrument. Archives of Neurology 2000, 57(6):877-884.
28. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
29. Monsch A., Bondi M., Butters N., Paulsen J., Salmon D., Brugger P., et al. A comparison of category and letter fluency in Alzheimer's disease and Huntington's disease. Neuropsychology 1994, 8(1):25-30.
30. Morris J. The clinical dementia rating (CDR): current version and scoring rules. Neurology 1993, 43:2412-2414.
31. Murphy K., Rich J., Troyer A. Verbal fluency patterns in amnestic mild cognitive impairment are characteristic of Alzheimer's type dementia. Journal of the International Neuropsychological Society 2006, 12:570-574.
32. Okonkwo O., Wadley V., Griffith H., Ball K., Marson D. Cognitive correlates of financial abilities in mild cognitive impairment. Journal of the American Geriatric Society 2006, 54:1745-1750.
33. Pakhomov, S., & Hemmy, L. (2013). A computational linguistic measure of clustering behavior on semantic verbal fluency task predicts risk of future dementia in the Nun Study. pii: S0010-9452(13)00137-8. doi: 10.1016/j.cortex.2013.05.009.
34. Palmqvist S., Hertze J., Minthon L., Wattmo C., Zetterberg H., Blennow K., et al. Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study. PLOS One 2012, 7(6):1-7.
35. Petersen R., Doody R., Kurz A., Mohs R., Morris J., Rabins P., et al. Current concepts in mild cognitive impairment. Archives of Neurology 2001, 58(12):1985-1992.
36. Petersen R., Smith G., Waring S., Ivnik R., Tangalos E., Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology 1999, 56:303-308.
37. Powell M., Smith G., Knopman D., Parisi J., Boeve B., Petersen R., et al. Cognitive measures predict pathologic Alzheimer disease. Archives of Neurology 2006, 63:865-868.
38. Pozueta A., Rodriguez-Rodriguez E., Vazquez-Higuera J., Mateo I., Sanchez-Juan P., Gonzalez-Perez S., et al. Detection of early Alzheimer's disease in MCI patients by the combination of MMSE and an episodic memory test. BMC Neurology 2011, 11(78):1-5.
39. Price S., Kinsella G., Ong B., Storey E., Mullaly E., Phillips M., et al. Semantic verbal fluency strategies in amnestic mild cognitive impairment. Neuropsychology 2012, 26(4):490-497.
40. R Core Team R: A language and environment for statistical computing 2012, R Foundation for Statistical Computing, Retrieved from. http://www.R-project.org/.
41. Reitan R. Validity of the trail making test as an indicator of organic brain damage. Perceptual Motor Skills 1958, 8:271-276.
42. Robin X., Turck N., Hainard A., Tiberti N., Lisacek F., Sanchez J.-C., et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011, 12:77.
43. Salloway S., Correia S., Richardson S. Key lessons learned from short-term treatment trials of cholinesterase inhibitors for MCI. International Psychogeriatrics 2007, 20(1):40-46.
44. Sing T., Sander O., Beerenwinkel N., Lengauer T. ROCR: Visualizing the performance of scoring classifiers, 1.0-4 2009, Retrieved from. http://cran.r-project.org/package=ROCR.
45. Tabert M., Manly J., Liu X., Pelton G., Rosenblum S., Jacobs M., et al. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Archives of General Psychiatry 2006, 63:916-924.
46. Thal L., Ferris S., Kirby L., Block G., Lines C., Yuen E., et al. A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment. Neuropsychopharmacology 2005, 30(6):1204-1215.
47. The Psychological Corporation WAIS-III - WMS-III technical manual 1997, Harcourt Brace & Co, San Antonio.
48. Triebel K., Martin R., Griffith H., Marceaux J., Okonkwo O., Harrell L., et al. Declining financial capacity in mild cognitive impairment: a 1-year longitudinal study. Neurology 2009, 73:928-934.
49. Troyer A. Normative data for clustering and switching on verbal fluency tasks. Journal of Clinical and Experimental Neuropsychology 2000, 22(3):370-378.
50. Troyer A., Moscovitch M. Cognitive processes of verbal fluency tasks. The Quantified process approach to neuropsychological assessment 2006, 143-157. Taylor and Francis, New York, New York. A. Poreh (Ed.).
51. Troyer A., Moscovitch M., Winocur G., Alexander M., Stuss D. Clustering and switching on verbal fluency: the effects of focal frontal- and temporal-lobe lesions. Neuropsychologia 1998, 36(6):499-504.
52. Visser P., Verhey F., Hofman P., Scheltens P., Jolles J. Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment. Journal of Neurology, Neurosurgery, and Psychiatry 2002, 72:491-497.
53. Vogel A., Gade A., Stokholm J., Waldemar G. Semantic memory impairment in the earliest phases of Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 2005, 19:75-85.
54. Walhovd K., Fjell A., Brewer J., McEvoy L., Fenneme-Notestine C., Hagler D., et al. Combining MR imaging, positron emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease. American Journal of Neuroradiology 2010, 31:347-354.
55. Westman E., Muehlboeck J.-S., Simmons A. Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion. NeuroImage 2012, 62:229-238.
56. Ye J., Farnum M., Yang E., Verbeeck R., Lobanov V., Raghavan N., et al. Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data. BMC Neurology 2012, 12(46):1-12.
57. Zhang D., Shen D., ADNI Predicting future clinical changes of MCI patients using longitudinal and multimodal biomarkers. PLOS One 2012, 7(3):1-15.